Literature DB >> 10996729

Telomerase activity and telomere length in benign and malignant human thyroid tissues.

M Kammori1, K Takubo, K Nakamura, E Furugouri, H Endo, H Kanauchi, Y Mimura, M Kaminishi.   

Abstract

Several studies have demonstrated that telomerase is activated and telomere length is altered in various types of tumors. In this study, we investigated telomerase activities and telomere length in 21 thyroid tumors. Telomerase activity was detected in 11 of 12 thyroid cancers and three of nine follicular adenomas. The mean telomere lengths in the cancers tissue and follicular adenomas were lower than in the respective background tissues, the differences being significant (P=0.0055 and P<0.006), respectively. Our findings suggest that change in telomerase activity and telomere length may be important for development of thyroid tumors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10996729     DOI: 10.1016/s0304-3835(00)00547-4

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

Review 1.  Telomerase and the endocrine system.

Authors:  Furio Pacini; Silvia Cantara; Marco Capezzone; Stefania Marchisotta
Journal:  Nat Rev Endocrinol       Date:  2011-03-29       Impact factor: 43.330

2.  Correlation of telomere length to malignancy potential in non-melanoma skin cancers.

Authors:  Hanae Yamada-Hishida; Yoshimasa Nobeyama; Hidemi Nakagawa
Journal:  Oncol Lett       Date:  2017-10-26       Impact factor: 2.967

3.  Thyroid carcinomas that express telomerase follow a more aggressive clinical course in children and adolescents.

Authors:  A M Straight; A Patel; C Fenton; C Dinauer; R M Tuttle; G L Francis
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

4.  Telomere length is related to alternative splice patterns of telomerase in thyroid tumors.

Authors:  Yongchun Wang; Alan K Meeker; Jeanne Kowalski; Hua-Ling Tsai; Helina Somervell; Christopher Heaphy; Lauren E Sangenario; Nijaguna Prasad; William H Westra; Martha A Zeiger; Christopher B Umbricht
Journal:  Am J Pathol       Date:  2011-07-16       Impact factor: 4.307

5.  Telomeres and thyroid cancer.

Authors:  Marco Capezzone; Stefania Marchisotta; Silvia Cantara; Furio Pacini
Journal:  Curr Genomics       Date:  2009-12       Impact factor: 2.236

6.  Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study.

Authors:  Lisa Mirabello; Montserrat Garcia-Closas; Richard Cawthon; Jolanta Lissowska; Louise A Brinton; Beata Pepłońska; Mark E Sherman; Sharon A Savage
Journal:  Cancer Causes Control       Date:  2009-09-27       Impact factor: 2.506

7.  Shortened telomere length is associated with increased risk of cancer: a meta-analysis.

Authors:  Hongxia Ma; Ziyuan Zhou; Sheng Wei; Zhensheng Liu; Karen A Pooley; Alison M Dunning; Ulrika Svenson; Göran Roos; H Dean Hosgood; Min Shen; Qingyi Wei
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

8.  Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas.

Authors:  Paula Soares; Jorge Lima; Ana Preto; Patricia Castro; João Vinagre; Ricardo Celestino; Joana P Couto; Hugo Prazeres; Catarina Eloy; Valdemar Máximo; M Sobrinho-Simões
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

9.  Telomere length in peripheral blood leukocytes is associated with risk of colorectal cancer in Chinese population.

Authors:  Qin Qin; Jingwen Sun; Jieyun Yin; Li Liu; Jigui Chen; Yuxing Zhang; Tingting Li; Yun Shi; Sheng Wei; Shaofa Nie
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

Review 10.  Telomerase Reverse Transcriptase (TERT) Regulation in Thyroid Cancer: A Review.

Authors:  Brittany A McKelvey; Christopher B Umbricht; Martha A Zeiger
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-31       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.